HSTM vs INCY: fair value comparison
HealthStream, Inc. and Incyte Corporation · Updated 2026-09-12
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, HSTM currently sits closer to the top of our discount ranking. INCY carries the stronger quality grade.
| HSTM | INCY | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $29.67 | $121.47 |
| 12-month range | $20.34–$29.67 | $93.48–$125.01 |
| Sector rank | #34 of 113 Healthcare | #38 of 113 Healthcare |
| Quality grade | D | A |
| Leverage | Low | Low |
| Margin trend | Stable | Stable |
| Revenue growth | Modest | High |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | Mixed |
| DCF cross-check | Undervalued | Undervalued |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: HSTM fair value analysis · INCY fair value analysis